Firefly Neuroscience is a brand that specializes in decoding the intricacies of brain health and improving outcomes related to mental illnesses through groundbreaking and disruptive innovations. Formerly known as Elminda, Firefly Neuroscience is committed to providing innovative solutions that revolutionize the field of neuroscience. With their cutting-edge technology called BNA™, they have garnered the FDA's approval to enhance brain health.

Their mission is to decode the complexities of the brain and offer effective treatments for mental illnesses, ultimately improving the lives of individuals suffering from these conditions. Firefly Neuroscience provides comprehensive services to investors, clinicians, and researchers, assisting them in understanding and utilizing their groundbreaking technology. With a team of experienced professionals, including the Chief Executive Officer Jon Olsen, Chief Financial Officer Stephen Purcell, and Chief Marketing Officer Ian McLean, the brand is dedicated to advancing the field of neuroscience and transforming the landscape of brain health.

Learn more about Firefly Neuroscience and their groundbreaking solutions to unlock the true potential of brain health